SCHEMBL4359332

SCHEMBL4359332

O=C(Nc1ccccc1)N(Cl)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
HSD17B10 Q99714 3/20 0.54
ALDH1A1 P00352 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
MAPT P10636 1/20 0.54
ALOX15 P16050 1/20 0.54
TP53 P04637 1/20 0.50
EPHX1 P07099 1/20 0.50
TSHR P16473 1/20 0.50
EPHX2 P34913 1/20 0.50
CDK9 P50750 1/20 0.50
CLK4 Q9HAZ1 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
USP2 O75604 1/20 0.49
NAPRT Q6XQN6 1/20 0.47
MITF O75030 1/20 0.46
PAX8 Q06710 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14779843 0.88 TAAR1 (0.56) MEN1KMT2AHSD17B10ALDH1A1SMN1; SMN2
Biguanide SCHEMBL28252577 0.87 MEN1 (0.45) MEN1KMT2AHSD17B10ALDH1A1SMN1; SMN2
SCHEMBL2068765 0.81 SMN1; SMN2 (0.56) MEN1KMT2AHSD17B10ALDH1A1SMN1; SMN2
SCHEMBL18342989 0.81 SMN1; SMN2 (0.47) MEN1KMT2AHSD17B10ALDH1A1SMN1; SMN2
SCHEMBL11449286 0.79 NPSR1 (0.43) MEN1KMT2AHSD17B10ALDH1A1SMN1; SMN2
SCHEMBL2068767 0.79 NPSR1 (0.43) MEN1KMT2AHSD17B10ALDH1A1SMN1; SMN2
SCHEMBL1382899 0.79 MEN1 (0.67) MEN1KMT2AHSD17B10ALDH1A1SMN1; SMN2
SCHEMBL10791571 0.79 MEN1 (0.59) MEN1KMT2AHSD17B10ALDH1A1SMN1; SMN2
SCHEMBL30879612 0.79 MEN1 (0.59) MEN1KMT2AHSD17B10ALDH1A1SMN1; SMN2
SCHEMBL11250302 0.78 TSHR (0.61) MEN1KMT2AHSD17B10ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210219546-A1 METHODS OF TREATING CROP PLANTS ALTER DOMUS US LLC 2021-07-22 US disclosed
EP-3294052-A1 METHODS OF TREATING CROP PLANTS Agrofresh, Inc. (US) 2018-03-21 EP disclosed
WO-2016182995-A1 METHODS OF TREATING CROP PLANTS AGROFRESH INC (US) 2016-11-17 WO disclosed
US-20150282479-A1 METHODS OF TREATING CROP PLANTS AGROFRESH, INC. 2015-10-08 US disclosed
US-9055741-B2 Contacting crop plants with compositions ROHM AND HAAS COMPANY (US) 2015-06-16 US disclosed
CN-104628659-A Pyrazine-aryle urea derivatives with anti-tumor function and preparation method and application thereof UNIV GUANGXI NORMAL 2015-05-20 CN disclosed
EP-1856976-B1 Contacting crop plants with compositions ROHM & HAAS (US) 2014-09-03 EP disclosed
CN-101528190-B Shampoo compositions LION CORP 2013-03-20 CN disclosed
CN-101528190-A Shampoo compositions LION CORP (JP) 2009-09-09 CN disclosed
EP-2070419-A1 A liquid composition for treating plants Rohm and Haas Company (US) 2009-06-17 EP disclosed
EP-1856976-A2 Contacting crop plants with compositions Rohm and Haas Company (US) 2007-11-21 EP disclosed
US-20070265166-A1 Contacting crop plants with compositions ALTER DOMUS US LLC 2007-11-15 US disclosed
US-20070117720-A1 Compositions with cyclopropenes AGROFRESH, INC. 2007-05-24 US disclosed
EP-1787513-A2 Compositions with cyclopropenes Rohm and Haas Company (US) 2007-05-23 EP disclosed
US-20060160704-A1 Plant growth regulation BASEL RICHARD M 2006-07-20 US disclosed
EP-1680960-A1 Plant growth regulation Rohm and Haas Company (US) 2006-07-19 EP disclosed
CN-1110478-C Biocidal benzylbiphenyl derivatives JANSSEN PHARMACEUTICA NV (BE) 2003-06-04 CN disclosed
CN-1295562-A Biocidal benzylbiphenyl derivatives JANSSEN PHARMACEUTICA NV (BE) 2001-05-16 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265166-A1 Contacting crop plants with compositions PIN1, MYB, CROCC MEN1 4248/4885KMT2A 2081/4885HSD17B10 1077/4885
US-20060160704-A1 Plant growth regulation MYB, SLTM, YAP1 MEN1 3961/4885KMT2A 2987/4885HSD17B10 615/4885
US-20150282479-A1 METHODS OF TREATING CROP PLANTS CYCS, NOP2, CNPY3 MEN1 4372/4885KMT2A 2541/4885HSD17B10 382/4885
US-20070117720-A1 Compositions with cyclopropenes MYB, OSBP, FAR1 MEN1 3749/4885KMT2A 3786/4885HSD17B10 341/4885
US-20210219546-A1 METHODS OF TREATING CROP PLANTS CYCS, NOP2, CNPY3 MEN1 4372/4885KMT2A 2541/4885HSD17B10 382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.